Journal of Antivirals & Antiretrovirals
Open Access

ISSN: 1948-5964

+44 1300 500008

Journal of Antivirals & Antiretrovirals : Citations & Metrics Report

Articles published in Journal of Antivirals & Antiretrovirals have been cited by esteemed scholars and scientists all around the world. Journal of Antivirals & Antiretrovirals has got h-index 22, which means every article in Journal of Antivirals & Antiretrovirals has got 22 average citations.

Following are the list of articles that have cited the articles published in Journal of Antivirals & Antiretrovirals.

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Total published articles	59	57	32	59	77	13	11	20	37	22	37	55	22	12
Research, Review articles and Editorials	1	0	5	42	32	12	10	14	27	21	33	44	21	10
Research communications, Review communications, Editorial communications, Case reports and Commentary	48	57	27	17	45	1	1	6	10	1	4	11	1	2
Conference proceedings	0	0	0	0	0	0	35	51	125	100	191	0	125	177
Citations received as per Google Scholar, other indexing platforms and portals	98	160	172	269	223	172	219	195	170	116	60	36	26	58

Journal total citations count	2004
Journal impact factor	5.32
Journal 5 years impact factor	5.62
Journal cite score	5.3
Journal h-index	22
Journal h-index since 2019	17

Important citations (1101)

lu dy, lu tr, lu y, sastry n, wu hy (2016) discover natural chemical drugs in modern medicines. metabolomics (los angel) 6: 2153-0769. View at Publisher View at Google Scholar
zhang hj, li wf, fong hh, soejarto dd (2016) discovery of bioactive compounds by the uic-icbg drug discovery program in the 18 years since 1998. molecules 21: 1448. View at Publisher View at Google Scholar
li wf, wang j, zhang jj, song x, ku cf, et al .(2015) henrin a: a new anti-hiv ent-kaurane diterpene from pteris henryi. international journal of molecular sciences. 16: 27978-27987. View at Publisher View at Google Scholar
naga anusha p. antiretroviral strategies for treatment of hiv. j antivir antiretrovir. 2011;1:2. View at Publisher View at Google Scholar
yong lu d, ren lu t, ying wu h (2011) treatment of influenza virus infection s with chinese medicine. adv pharmacoepidem drug safety 1: e104. View at Publisher View at Google Scholar
basu a, mills dm, mitchell d, ndungo e, williams jd, et al. (2015) novel small molecule entry inhibitors of ebola virus. journal of infectious diseases 22: 223. View at Publisher View at Google Scholar
lu dy, lu tr, wu hy (2012) avian flu; pathogenesis and therapy. anti-infective agents 10: 124-129. View at Publisher View at Google Scholar
wang j, cheng h, ratia k, varhegyi e, hendrickson wg, et al. (2014) a comparative high-throughput screening protocol to identify entry inhibitors of enveloped viruses. journal of biomolecular screening 19: 100-107. View at Publisher View at Google Scholar
wrzesiÅ„ska b, wieczorek p, obrÄ™palska-stÄ™plowska a (2016) recombination-based generation of the agroinfectious clones of peanut stunt virus. journal of virological methods 237: 179-186. View at Publisher View at Google Scholar
hill am, pozniak al (2016) how can we achieve universal access to low-cost treatment for hiv? journal of virus eradication 2: 193. View at Publisher View at Google Scholar
soumya d, hima bindu a (2011) opportunistic diseases as a consequence of hiv/aids. j aids clin res 2: 5. View at Publisher View at Google Scholar
naga anusha p (2011) antiretroviral strategies for treatment of hiv. j antivir antiretrovir 1: 2. View at Publisher View at Google Scholar
achhra ac, mwasakifwa g, amin j, boyd ma (2016) efficacy and safety of contemporary dual-drug antiretroviral regimens as first-line treatment or as a simplification strategy: a systematic review and meta-analysis. the lancet hiv 3: e351-e360. View at Publisher View at Google Scholar
hima bindu a, naga anusha p (2011) adverse effects of highly active anti-retroviral therapy (haart). j antivir antiretrovir 3: 060-064. View at Publisher View at Google Scholar
hemkens lg, ewald h, santini-oliveira m, bühler je, vuichard d, et al. (2015) comparative effectiveness of tenofovir in treatment-naive hiv-infected patients: systematic review and meta-analysis. hiv clinical trials 16: 178-189. View at Publisher View at Google Scholar
landman r, koulla-shiro s, sow ps, ngolle m, diallo mb, et al. (2014) evaluation of four tenofovir-containing regimens as first-line treatments in cameroon and senegal: the anrs 12115 dayana trial. antivir ther 19: 51-59. View at Publisher View at Google Scholar
vitoria m, hill am, ford np, doherty m, khoo sh, et al. (2016) choice of antiretroviral drugs for continued treatment scale-up in a public health approach: what more do we need to know?. journal of the international aids society 19: 1. View at Publisher View at Google Scholar
marcotullio s, andreoni m, antinori a, d’arminio monforte a, di perri g, et al. (2012) rapporteur committee. the less drugs regimens (ldrs) therapy approach in hiv-1: an italian expert panel perspective for the long-term management of hiv-1 infection. new microbiol 35: 259-277. View at Publisher View at Google Scholar
patel da, snedecor sj, tang wy, sudharshan l, lim jw, et al. (2014) 48-week efficacy and safety of dolutegravir relative to commonly used third agents in treatment-naive hiv-1–infected patients: a systematic review and network meta-analysis. plos one 9: e105653. View at Publisher View at Google Scholar
williams i, churchill d, anderson j, boffito m, bower m, et al. (2012) british hiv association guidelines for the treatment of hivâ€1â€positive adults with antiretroviral therapy 2012. hiv medicine 13: 1-6. View at Publisher View at Google Scholar
Prev 1 2 ... 44 45 46 47 48 49 50 51 52 53 54 55 56 Next »

Top